Home
News
Create
Screeners
Insights
Godavari Drugs
92.
00
-0.78
(-0.84%)
Market Cap
₹93.21 Cr
PE Ratio
21.48
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-0.84%
1M
+18.39%
6M
+6.16%
1Y
+0.55%
5Y
+101.09%
View Company Insights
Latest news about Godavari Drugs
Godavari Drugs: Prashant Shrimal Files SEBI Disclosure for Share Acquisition
Mar 23, 2026
Godavari Drugs Limited completed significant capital raising through allotment of 23,60,065 convertible warrants and 25,96,935 equity shares on preferential basis. Promoter group member Prashant Shrimal filed SEBI disclosure confirming acquisition of 1,12,360 equity shares, representing 1.11% shareholding and 0.90% diluted shareholding, with multiple other promoters also filing regulatory disclosures for their respective warrant acquisitions.
Godavari Drugs Limited Shareholders Approve Preferential Equity Share and Convertible Warrant Issuance at EGM
Feb 12, 2026
Godavari Drugs Reports Q3FY26 Results, Approves ₹5.50 Crore Working Capital Loan
Feb 11, 2026
Godavari Drugs Board Approves Preferential Issue of Convertible Warrants and Equity Shares Worth ₹44.12 Crores
Jan 15, 2026
Godavari Drugs Limited Issues Clarification on Share Price Movement to BSE
Jan 08, 2026
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO